DexCom price to book ratio DXCM

Market value divided by the book value of the company's net assets, since 2011.

Today, Oct 23, 2026: 11.2×
10-year median: 20.1×
Against its 10-year history: 10th; percentile: 0 is its lowest day, 100 its highest
10-year range: 7.9× to 43.4×
Peer median: 2.9×

DexCom's price to book ratio is 11.2× as of Oct 23, 2026.

That is below its ten-year median of 20.1×, lower than on 90% of days in the last ten years.

Over that time it ranged from 7.9× in Nov 2025 to 43.4× in Jul 2020.

The median for 9 medical device stocks of a similar size is 2.9×.

Price to book ratio over time

median 20.1×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	11.2×	7.9×	13.3×
2025	9.7×	7.9×	17.6×
2024	15.8×	10.5×	25.9×
2023	21.1×	14.1×	24.5×
2022	24.0×	12.3×	25.6×
2021	24.4×	16.9×	29.3×
2020	23.7×	20.2×	43.4×
2019	26.1×	15.5×	27.2×
2018	18.7×	11.4×	26.5×
2017	13.0×	10.9×	27.5×
2016	19.3×	19.3×	33.5×
2015	34.5×	33.0×	46.9×
2014	36.7×	26.2×	41.7×
2013	33.7×	12.2×	33.7×
2012	11.4×	5.3×	11.8×
2011	5.6×	4.1×	7.1×

Against its peers

Companies in Medical - Devices nearest DexCom's size, closest first, today.

Company	Price to book ratio
DXCMDexCom	11.2×
GEHCGE HealthCare Technologies	2.9×
ZBHZimmer Biomet	1.5×
EWEdwards Lifesciences	4.8×
BSXBoston Scientific	2.7×
SYKStryker	4.9×
MDTMedtronic	2.4×
ABTAbbott Laboratories	3.5×
LIVNLivaNova	3.4×
ITGRInteger	2.5×
Peer median	2.9×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on DexCom

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.